Research & Development  

With pressure on the chicken to perform better and the density in poultry concentrated areas increasing, variants/ newer diseases are being encountered continuously.

Resultantly, the poultry farmer’s umbrella against diseases is shrinking by the day.

It is this dilemma that is receiving the most attention in our research facilities, where there is a continuous hunt on the part of INDOVAX Scientists to search for newer solutions and, thereby, counter the new emerging threats to poultry.

Obviously the solution lies in not being with the disease, but in being one-up on it in constantly anticipating future challenges, and being ready and waiting, before they assume economically dangerous proportions.

Finding appropriate scientific solutions to disease problems remains the highest priority for the company.

That is where INDOVAX has shown the way...and stayed ahead of everyone else.

The many firsts from INDOVAX in India

•  Marek’s frozen MD vaccine (1991)

•  Intermediate Strain  of   IBD vaccine (1993)

•  EDS’76 inactivated  vaccine (1994)

•  Invasive Intermediate Strain of IBD vaccine (1995-96)

•  Fowl Cholera bacterin using homologous strain (1998)

•  Diluent  delivery system that ensures vaccine sterility   

   during reconstitution and administration without being

   touched by human hands (1998-99)

•  Bursa B2K Strain - specially developed IBD vaccine 

   for broilers   (2000-01)